SGTB is involved in the regulation of protein folding and assembly, interacting with molecular chaperones. The chemicals listed are not direct activators of SGTB but may influence its activity or expression indirectly by affecting related cellular mechanisms. Hsp90 inhibitors like 17-AAG, Geldanamycin, and Radicicol can alter chaperone-mediated protein folding processes, potentially impacting the function of SGTB in these pathways. Proteasome inhibitors such as MG132 and Bortezomib are known to affect protein degradation and can induce cellular stress responses, which might influence SGTB activity. Salubrinal and Tunicamycin, targeting eIF2α and N-linked glycosylation respectively, can modulate ER stress and protein folding pathways, potentially affecting SGTB. Thapsigargin, by inducing calcium-mediated ER stress, and Chloroquine, an autophagy inhibitor, also influence cellular stress pathways that could indirectly impact SGTB function.
Compounds like 4-Phenylbutyrate and Curcumin, known as chemical chaperones or modulators of multiple signaling pathways, can have an indirect effect on SGTB by aiding in protein folding and reducing cellular stress. Additionally, inducers of heat shock proteins, such as J2, may modulate the chaperone network in a way that influences SGTB's activity. These compounds, through their impact on protein folding, chaperone function, and stress response mechanisms, provide insight into the potential roles and regulatory mechanisms associated with SGTB. They highlight the importance of further research to understand SGTB's specific functions and interactions within the complex network of cellular protein management systems.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $66.00 $153.00 | 16 | |
A Hsp90 inhibitor, 17-AAG may indirectly affect SGTB by influencing the chaperone-mediated protein folding process. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib, a proteasome inhibitor, might indirectly affect SGTB activity through its role in protein turnover and stress response. | ||||||
Radicicol | 12772-57-5 | sc-200620 sc-200620A | 1 mg 5 mg | $90.00 $326.00 | 13 | |
Radicicol, an Hsp90 inhibitor, can potentially influence SGTB function by altering chaperone-mediated protein folding mechanisms. | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $33.00 $102.00 | 87 | |
Salubrinal, a selective inhibitor of eIF2α dephosphorylation, can indirectly affect SGTB by modulating cellular stress response pathways. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin, an inhibitor of N-linked glycosylation, can influence SGTB by inducing ER stress and affecting protein folding. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin, a SERCA pump inhibitor, can indirectly impact SGTB activity by inducing calcium-mediated ER stress. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine, an autophagy inhibitor, might influence SGTB by affecting cellular degradation pathways and stress responses. | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $75.00 $163.00 $622.00 $4906.00 $32140.00 | 43 | |
4-Phenylbutyrate, a chemical chaperone, can potentially modulate SGTB activity by aiding in protein folding and reducing cellular | ||||||